Aytu Biopharma, Inc.
AYTU
$1.27
$0.010.79%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 458.18% | 118.15% | -87.91% | 59.90% | 96.71% |
| Total Depreciation and Amortization | -25.24% | -22.57% | -8.13% | -12.45% | -18.81% |
| Total Amortization of Deferred Charges | -81.82% | -81.76% | 6.80% | -- | -- |
| Total Other Non-Cash Items | -193.69% | -139.60% | -80.12% | 113.63% | -40.63% |
| Change in Net Operating Assets | 171.81% | 67.92% | -101.71% | -90.30% | -84.28% |
| Cash from Operations | 2,251.85% | -463.98% | -108.41% | 91.26% | 94.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 78.06% | -1,025.00% | -- |
| Cash from Investing | 183.33% | 601.32% | 78.06% | -4,600.00% | -3,380.00% |
| Total Debt Issued | -- | -- | 309.62% | -99.39% | -- |
| Total Debt Repaid | -119.34% | -25.41% | -588.61% | 801.37% | -915.38% |
| Issuance of Common Stock | -- | -- | 31.92% | -100.00% | -92.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 78.85% | -153.01% | 100.00% | 100.00% |
| Cash from Financing | -2,090.48% | 133.32% | 119.76% | -79.48% | 93.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.67% | 103.38% | -93.54% | 171.74% | 89.91% |
